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The isozymogens PGA-3 and PGA-5 of human pepsinogen A were digested with endoproteinase Lys-C. The peptides 
were separated by reverse-phase HPLC. PGA-5 showed a peak strongly absorbing at 254 nm absent in PGA-3. Analysis 
of amino acid composition using the Pica-Tag methodology combined with DABITC-sequencing reveals the sequence 
Tyr-Phe-Pro-Gln-Trp-Lys (peptide 3743 of the activation segment). This confirms a study at the DNA level by our group 
[16] suggesting a Glu > Lys mutation at position 43 in the activation segment of PGA-5. Furthermore, it is proposed 
that the number of genetic variants of PGA is higher than is actually seen by electrophoresis. 
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1. INTRODUCTION 
Human pepsinogen A (PGA), the inactive 
precursor of pepsin A (EC 3.4.23. l), is synthesized 
in the gastric mucosa. It consists of a single 
polypeptide chain of 373 amino acids with a 
molecular mass of 40 300 Da [ 1,2]. During activa- 
tion an activation segment of 47 residues is re- 
leased from the N-terminus giving rise to pepsin 
[3,4]. After agar or polyacrylamide gel elec- 
trophoresis, PGA reveals a multibanded pattern, 
consisting of l-5 isozymogens, designated 
PGA2-5 and 5s in decreasing order of anodal 
mobility [5-71. PGA-5S is only rarely seen whereas 
PGA-2 is a posttranslational modification of 
PGA-3 [6,8]. The main PGA isozymogens, 
PGA-3, -4 and -5, differ by approximately one 
charge unit [9] as may be estimated from the elec- 
trophoretic fractionation and the order of elution 
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from anion-exchange columns. Whitecross et al. 
[IO] and Korsnes and Gedde-Dahl [6] have 
demonstrated that PGA-3 and -5 are converted to 
pepsins which are indistinguishable by elec- 
trophoresis. Hence charge differences between 
PGA-3 and -5 must be present in the activation 
segment. Up to now it has not been possible to 
identify the amino acid differences between the 
various PGA isozymogens by protein sequencing. 
In this paper we demonstrate a Glu > Lys substitu- 
tion in the activation segment leading to a charge 
difference of two units. 
2. MATERIALS AND METHODS 
2.1. Materials 
Endoproteinase Lys-C from Lysobacter enzymogenes was 
obtained from Boehringer and was used without further 
purification. Reagents for amino acid analysis and sequencing 
(TFA, DABITC, PITC, TEA, heptane, ethyl acetate, n-butyl 
acetate, pyridine, constant boiling HCl) were obtained from 
Pierce (sequanal grade) as well as urea and 2-mercaptoethanol. 
Acetonitrile was an HPLC-grade product from Rathburn. 
Water was deionized, then purified with the Milh-Q water 
system. All other chemicals were at least of analytical grade. 
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2.2. Purification of PGA-3 and PGA-5 3. RESULTS 
PGA-3 and PGA-5 have been isolated from a human 
stomach (phenotype BD) obtained after gastrectomy. The 
isozymogens were purified on a Sephadex G75 column com- 
bined with consecutive separations with FPLC using Mono-Q 
and Superose 12 columns as described previously [1 11. 
The complete primary structure of human PGA 
has already been deduced from nucleotide se- 
2.3. Carboxymethylation 
Reduction and S-carboxymethylation were performed as 
described by Crestfield et al. [12]. In short, 2-3 mg PGA was 
dissolved in 12 ml of a solution containing 8 M urea, 0.36 M 
Tris and 5.4 mM disodium EDTA, adjusted to pH 8.6 with 
HCI. After the addition of 150 ~1 2-mercaptoethanol the solu- 
tion was gently stirred and held under nitrogen. After 4 h 1 ml 
of a freshly prepared solution containing 1 M NaOH and 
1.53 M iodoacetic acid was added. Alkylation was allowed to 
proceed under nitrogen and in the dark. 15 min after the addi- 
tion of iodoacetic acid, the carboxymethylation was stopped by 
adding 150 ~1 2-mercaptoethanol. The samples were dialysed 
exhaustively for at least 2 x 24 h in the dark against 0.1 M 
NH4HCOs and freeze-dried. 
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2.4. Cleavage by endoproteinase Lys-C 
The freeze-dried samples of PGA-3 (2 mg) and PGA-5 (3 mg) 
were dissolved in 1.25 ml and 1.50 ml of 0.1 M NHdHCOj, pH 
8.0, respectively. Enzymatic degradation of PGA by endopro- 
teinase Lys-C was performed by incubation at 37°C for 2 h, at 
an enzyme to substrate ratio of 1:75 (w/w). After this incuba- 
tion the same amount of enzyme was added, and after 22 h the 
digestion was stopped by addition of 6 M HCI (4081) and 
subsequently analyzed by HPLC for peptide mapping. 
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2.5. High-performance peptide mapping chromatography 
Chromatography was performed with a Waters HPLC- 
system consisting of two 6000 A pumps, a 680 gradient con- 
troller, a U6K injector with a 2 ml sample loop and a 440 detec- 
tor. Digestions were chromatographed on a column (250 x 
4.6 mm i.d.) packed with Nucleosil lOC18 (Macherey-Nagel) 
and detected at 214 and 254 nm. Elution was performed with a 
linear gradient at a flow rate of 1 ml/min. The gradient began 
at 5% B (= 0.1% TFA in 67% acetonitrile; A = 0.1% TFA in 
water) and rose to 70% at 30 min. Where necessary, the column 
effluent was collected into tubes and aliquots were removed for 
amino acid compositional analysis. 
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2.6. Amino acid analysis by the Pica-Tag method 
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Amino acid analyses of the peptides were carried out ac- 
cording to the protocol developed by Bidlingmeyer et al. [13] 
and described in detail in the Pica-Tag amino acid analysis 
operator’s manual [ 141. The Pica-Tag method is based upon a 
gaseous acid hydrolysis of the peptides followed by the forma- 
tion of a PTC-derivative of the amino acids via derivatization 
with PITC. The derivatized amino acids undergo HPLC- 
separation on a reversed-phase Nova-Pak Cl8 column (150 x 
3.9 mm i.d.) which is specially selected and tested for suitability 
in separating PTC amino acids (Pica-Tag column). 
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2.7. Amino acid sequence determination 
N-terminal analysis was carried out with the manual liquid- 
phase DABITC/PITC double coupling procedure as described 
by Chang [15]. 
Fig. 1. Separation by reversed-phase HPLC of peptides from the 
digests of PGA-3 (a) and PGA-5 (b) by lysylendopeptidase-C. 
For experimental conditions see section 2.5. Peak identification 
and sequences are given in fig.2. In contrast to the other 
peptides, peak 10 also strongly absorbed at 254 nm (not 
shown). 
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+2--1+-6+ -7 -+5---1 -1 --10--1 
i-------3 --8 B-4 --I 
Fig.2. Peak identification and sequence of the major fragments generated by digestion of PGA-3 (upper part) and PGA-5 (lower part) 
by lysylendopeptidase-C according to the analysis of PTC amino acids combined with DABITC-sequencing. Fragments are numbered 
according to their elution position on HPLC (see fig.1). The complete amino acid sequence of the activation segment of human 
pepsinogen A is shown here, according to data in references [1,16]. 
quences [l]. These data have shown that lysine 
residues are exclusively located in the activation 
segment. Detailed analysis of the PGA gene com- 
plex at the DNA level by our group has revealed a 
nucleotide substitution giving rise to a Glu > Lys 
substitution of the 43rd amino acid residue of the 
activation segment [161. It has been postulated that 
these residues are present in PGA-3 and PGA-5, 
respectively. On the basis of these previous DNA 
sequence analyses, cleavage of PGA-3 and PGA-5 
by endoproteinase Lys-C should generate 5 and 6 
peptides, respectively. These fragments, covering a 
large part of the total sequence of the activation 
segment of PGA, were in fact identified in the pep- 
tide maps of PGA-3 and PGA-5 (fig.1). The 
assignment of each peak, deduced by the amino 
acid compositional analysis combined with partial 
N-terminal analysis by DABITC-sequencing, is 
given in fig.2. Analysis of the peptide maps show- 
ed that cleavage had occurred primarily on the C- 
terminal side of lysine residues. The number of 
peaks however exceeds the expected number of 
theoretical peptides because of irregular or in- 
complete cleavage, largely due to Lys-Lys se- 
quences (see fig.2). 
4. DISCUSSION 
PGA is a highly polymorphic protein, not only 
in man but also in other mammals, e.g. monkeys, 
bears and rabbits [ 17-191. For example, in rabbits 
6 different PGA proteins are sequenced, five of 
them having a different amino acid sequence of the 
activation segment [ 191. In humans, up to 4 
primary gene products are found after 
polyacrylamide gel electrophoresis named PGA-3, 
-4, -5 and -5s. Table 1 shows the existence of 4 dif- 
ferent activation segments. Sequence II belongs to 
PGA-3 whereas sequence III belongs to PGA-5 
([16] and this study). According to Evers et al. 
[16,20], PGA4 has also sequence II: it differs 
from PGA-3 in having 4 amino acid substitutions 
in the pepsin part. According to Foltmann [9], the 
preparation sequenced by Foltmann and Axelsen 
[4] (= sequence I) consisted mainly of PGA-3. 
Thus several components are present in the elec- 
trophoretic zone called PGA-3 indicating that the 
number of genetic variants is higher than is actual- 
ly seen by electrophoresis. The sequence of 
PGA-5S is unknown nor is it known to which 
PGA-isozymogen sequence IV belongs. 
There is evidence that the amino acid exchange 
rate is higher in the activation peptide than in the 
pepsin part [2,21]. This is of interest in view of the 
molecular evolution of pepsinogens and useful for 
the molecular taxonomy of the animals whose pep- 
sinogen is sequenced. Because of the fact that 
lysine residues are almost completely restricted to 
the activation segment of PGA, the peptide map- 
ping technique presented here will be useful in 
analyzing genetic variants of PGA. Because of its 
reasonably high specificity endoproteinase Lys-C 
generates only a few fragments thus giving rise to 
simple peptide maps which are easy to interpret. In 
addition, lysine is often involved in substitutions 
between PGA proteins of different animals (fig.3) 
Table 1 
The different amino acid sequences of the activation segments 
of human pepsinogen A according to the literature 
Sequence Amino acid position Isozymogen Reference(s) 
18 20 42 43 
I Ile Asp ND ND PGA-3 4 
II Ser Arg Trp Glu PGA-3,4 1,16,20 
III Ser Arg Trp Lys PGA-5 16,20 
IV Ser Arg Arg Lys PGA-? 3 
In this report we could confirm sequence II for PGA-3 and 
sequence 111 for PGA-5. ND, not determined 
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Human 
Japanese Monkey -I-----V------.-N-S-H------_------_---_~____~~~____ 
Rhesus Monkey -~-----~-------~-~-~----------_~---~_____~~____ 
Asiatic Black Bear ~~~____~~-----~~-~-~---------_~P--_S-__~__---~~_~~~ 
Rabbit ~~H----v ______ KN-I-K___~_Y_-T-~P-~-T__~_~.~ :F;; 
Swine _LV____V------QN-IKD-K------T_KH-__S____..E-~- 
Bovine SW-I--VK-----QN-I-N-K--E-MRT-KY-LGS--IR..E-A-- 
Chicken SIHR---KKG----KQ-KDH---E------PY--_S---S_-H-VL_TA__ 
Fig.3. Comparison of the amino acid sequence of the activation segments of human pepsinogen A [1,3,4,16] with those of Japanese 
monkey (Mucucu_fuscatu) [2,22], Rhesus monkey (Mucucu muluttu) [21], Asiatic black bear (Selenurctos thibetanus juponicus) [18], 
rabbit [19], porcine [23,24,25], bovine [26] and chicken [27] pepsinogens A. The amino acids are expressed in the single letter code 
recommended by the IUPAC-IUB Commission on Biochemical Nomenclature. When 2 types of residues were identified at one 
position, both are shown (small letter codes). Residue numbers are given based on the sequences of human and monkey pepsinogen 
A. The residues common to human pepsinogen A are shown by dashes. The dots indicate gaps to maximize homology. 
thus allowing intra- and interindividual difference [12] Crestfield, A.M., Moore, S. and Stein, W.H. (1963) J. 
studies. Biol. Chem. 238, 622. 
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